Back

Effect of hypertension duration and systolic blood pressure on dementia in patients with atrial fibrillation

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Adverse outcomes in atrial fibrillation: can they be prevented? Cognitive Function and Autonomy in Patients with Atrial Fibrillation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Daehoon Kim

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
State of the Art - Prediction of stroke and dementia in atrial fibrillation
Professor P. Kirchhof (Hamburg, DE)
Slides Video
Presentation thumbnail
Glucose is associated with future atrial fibrillation and heart failure already at prediabetes levels, a 19 year follow up of 243,665 subjects
Doctor V. Lind (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Predictors of thromboembolism in patients with atrial fibrillation and valvular heart disease according to the EHRA classification: beyond mitral stenosis and mechanical prosthetic heart valves
Miss L. Melgaard (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
Associate Professor L. Friberg (Bromma, SE)
Slides Video

Access the full session

Session thumbnail
Adverse outcomes in atrial fibrillation: can they be prevented?

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources